Critical appraisal:Huang X, Wang J, Chen Q, Jiang J 2014
Critical Appraisal
Huang X, Wang J, Chen Q, Jiang J. Mediastinal Lymph Node Dissection versus Mediastinal Lymph Node Sampling for Early Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. PLoS One 2014;9(10):e109979 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25296033.
- Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?
- Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?
- What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?
Key Facts
systematic review
1791
overall survival, local recurrence rate, distant metastasis rate, total complications rate
overall survival (HR = 0.77, 95% CI 0.55 to 1.08; P = 0.13)
local recurrence rate (RR = 0.93, 95% CI 0.68 to 1.28; P = 0.67)
distant metastasis rate (RR = 0.88, 95% CI 0.74 to 1.04; P = 0.15)
total complications rate (RR = 1.10, 95% CI 0.67 to 1.79; P = 0.72)
Conclusions can only be drawn for Stage I or very early stage resectable non-small cell cancer with no clinical or surgical evidence of lymph node involvement.
no
Evidence ratings
I
Low risk of bias | Comments: |
3 | Reason for decision: |
1 | Additional comments: |
- Article
- Huang X, Wang J, Chen Q, Jiang J. Mediastinal Lymph Node Dissection versus Mediastinal Lymph Node Sampling for Early Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. PLoS One 2014;9(10):e109979 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25296033.
- Assigned to
- User:Gavin.wright
- Topic area
- Guidelines:Lung cancer/Treatment/Non-small-cell stage I operable
- Clinical question
-
- Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?
- Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?
- What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?
- Study design
- systematic review
- Level of Evidence
- I
Section below only relevant for Cancer Council Project Officer